Egeria Project - Open metadata and governance for enterprises

The personas from Coco Pharmaceuticals are fictitious, although they are blended from the experiences of real people working with data today. They are used to illustrate the types of people that work with data in an organization and how they use Egeria to support their work.
These personas are responsible for leading sustainability improvements within the company's operations.
These personas are responsible for defining the security strategy for Coco Pharmaceuticals and ensuring compliance.
These personas are involved in an AI project to model consumers of Coco Pharmaceuticals' products and understand their future needs. It is very experimental at this time but has a lot of interest at board level.
These personas are investigating a potential incidence of fraud.
These personas are the executives whose full-time job is the governance and protection of the company. They oversee the programs that set policies and monitor, measure and feedback on compliance to the policies.
This is the IT Project Team enhancing the IT Systems to create a supplier/customer hub, to provide end-to-end monitoring of the manufacturing process, and to provide support for a data lake for the clinical research teams. This is their first use of
Bob Nitter supports the multitude of application systems that the company runs. Lemmie Stage does the integration backbone implementation that supports the information supply chains that shift data between the applications. Bob and Lemmie work for Polly. Polly has engaged external consultants Nancy Noah and Des Signa to help with their development of the new personalized medicine capabilities.
Coco Pharmaceuticals has its own manufacturing plants. Stew Faster is the general manager of the plants and is involved in the digitization program for manufacturing and distribution of the products.
These personas are involved in the clinical trials for new cancer drugs developed by the company. They have a new data pipeline to receive data from the participating hospitals. They are also collaborating on their findings as selected patients are given the new drug.
Raise an issue or comment below